emetine has been researched along with Carcinoma, Non-Small Cell Lung in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Hayase, R; Ichikawa, Y; Ito, A; Kondoh, Y; Maemoto, Y; Noritsugu, K; Ogawa, K; Osada, H; Sekine, S; Takase, S; Yoshida, M | 1 |
| Chang, H; Chang, SY; Huang, TW; Lin, YW; Shih, YL; Wu, TH | 1 |
| Cho, EB; Cho, JY; Jung, O; Kim, JH; Kim, SH; Lee, J; Lee, SY; Ryou, C; Ryu, BJ | 1 |
3 other study(ies) available for emetine and Carcinoma, Non-Small Cell Lung
| Article | Year |
|---|---|
Identification of a derivative of the alkaloid emetine as an inhibitor of the YAP-TEAD interaction and its potential as an anticancer agent.
Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Emetine; Humans; Lung Neoplasms; TEA Domain Transcription Factors; Transcription Factors; YAP-Signaling Proteins | 2023 |
Emetine Synergizes with Cisplatin to Enhance Anti-Cancer Efficacy against Lung Cancer Cells.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Cisplatin; Drug Resistance, Neoplasm; Drug Synergism; Drug Therapy, Combination; Emetics; Emetine; Humans; Lung Neoplasms; Neoplasm Proteins; Tumor Cells, Cultured | 2019 |
Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways.
Topics: beta Catenin; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Movement; Emetine; Humans; Lung Neoplasms; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Molecular Targeted Therapy; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-myc; Signal Transduction | 2015 |